BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
US Army
Argus Health
Baxter
Farmers Insurance
Deloitte
Moodys
Daiichi Sankyo
Covington

Generated: January 24, 2018

DrugPatentWatch Database Preview

Valacyclovir hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for valacyclovir hydrochloride and what is the scope of valacyclovir hydrochloride patent protection?

Valacyclovir hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma, Cipla Ltd, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Jubilant Generics, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, Watson Labs Inc, West-ward Pharms Int, Wockhardt, and Glaxosmithkline, and is included in fifteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Valacyclovir hydrochloride has one hundred and six patent family members in forty-five countries.

There are twenty-two drug master file entries for valacyclovir hydrochloride. Forty-nine suppliers are listed for this compound.
Summary for valacyclovir hydrochloride

US Patents and Regulatory Information for valacyclovir hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 078656-002 May 24, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 077655-002 May 24, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 201506-002 Apr 3, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 077478-002 May 24, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090370-002 Mar 16, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090682-002 May 24, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd V VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 203047-001 Apr 8, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 078070-001 May 24, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090216-002 May 24, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for valacyclovir hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for valacyclovir hydrochloride

Country Document Number Estimated Expiration
Hungary 9801872 ➤ Subscribe
Bulgaria 101833 ➤ Subscribe
Slovakia 285329 ➤ Subscribe
Iceland 4527 ➤ Subscribe
Japan 3350055 ➤ Subscribe
China 1179100 ➤ Subscribe
Denmark 0806943 ➤ Subscribe
Finland 973062 ➤ Subscribe
Brazil 9606768 ➤ Subscribe
Hungary 226131 ➤ Subscribe
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Fish and Richardson
Cerilliant
Cantor Fitzgerald
Medtronic
US Department of Justice
Fuji
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot